Angioplasty Balloons Market Report - Trends, Size, Share 2030
[Research Report] The angioplasty balloons market is projected to grow from US$ 2.71 billion in 2022 to US$ 3.60 billion by 2030, recording a CAGR of 3.6% from 2022 to 2030.
Market Insights and Analyst View:
The angioplasty balloons market forecast can help stakeholders in this marketplace plan their growth strategies. The report includes growth prospects, along with the angioplasty balloons market trends and their foreseeable impact during the forecast period.
An angioplasty is a technique used to widen narrowed or open clogged coronary arteries and restore blood flow. Value-based care, which focuses on cost-effectiveness and patient outcomes, is changing the healthcare sector. The market for angioplasty balloons will be influenced by the capacity of these devices to provide better patient outcomes, reduced rates of revascularization, and lower costs as compared to other available treatments. Compared to conventional surgical methods, angioplasty balloons provide a less invasive method of treating clogged arteries. The need for angioplasty balloons is rising as patients and medical professionals show a greater preference for less invasive procedures. The rising prevalence of cardiovascular diseases and increasing preference for minimally invasive procedures contribute to the growing angioplasty balloons market size. However, complications associated with angioplasty impede the growth of the market.
Growth Drivers:
Increasing Prevalence of Cardiovascular Diseases Drives Angioplasty Balloons Market
According to the World Health Organization (WHO), cardiovascular diseases are the most prominent cause of morbidity and mortality worldwide. Cardiovascular diseases include cerebrovascular disease, coronary heart disease, and rheumatic heart disease. Major lifestyle factors causing cardiovascular diseases and related difficulties are tobacco consumption, unhealthy diet, and physical inactivity, among others. According to the American Heart Association Inc., the cardiovascular disease-related deaths recorded in 2020 increased to 928,741 from 874,613 in 2019. In 2020, coronary heart disease was the leading cause (41.2%) of deaths attributable to cardiovascular diseases in the US, followed by stroke (17.3%), high blood pressure (12.9%), heart failure (9.2%), diseases of the arteries (2.6%), and other cardiovascular diseases (16.8%). Also, the World Heart Federation predicts more than 23 million cardiovascular disease-related deaths per year by 2030.
Moreover, cardiovascular risk factors are highly prevalent in Central and Western Europe, owing to smoking habits and heavy alcohol consumption rates, especially among men. More than 4 million Europeans die yearly from cardiovascular diseases, mainly due to coronary artery disease and stroke. The Middle East also has a high prevalence rate of cardiovascular diseases, which has surged the need for various interventions such as health education, lifestyle counseling, screening, and treatment in this region. According to the World Heart Federation, cardiovascular disease is the primary cause of death in the Middle East & North Africa, accounting for more than a third of all deaths or 1.4 million people annually. Thus, the increasing prevalence of cardiovascular diseases propels the angioplasty balloons market growth.
Angioplasty operations are considered by most to be safe, but there have been reported cases of problems developing during or age the surgery. A blood clot, irregular heartbeat, damage to a blood vessel or heart valve, stroke, allergic response to the stent material or drug-eluting stent, in-stent restenosis, or clogging of the stent's interior are a few of the risks involved in theangioplasty operations. While some of these risks are extremely dangerous, others might even be fatal. Furthermore, the patient might not have enough time in some circumstances to have an angioplasty. This typically occurs in the event of a heart attack. All of these problems hinder the angioplasty balloons market growth.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Angioplasty Balloons Market: Strategic Insights
Market Size Value in US$ 2.71 billion in 2022 Market Size Value by US$ 3.60 billion by 2030 Growth rate CAGR of 3.6% from 2022 to 2030 Forecast Period 2022-2030 Base Year 2022
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Angioplasty Balloons Market: Strategic Insights
| Market Size Value in | US$ 2.71 billion in 2022 |
| Market Size Value by | US$ 3.60 billion by 2030 |
| Growth rate | CAGR of 3.6% from 2022 to 2030 |
| Forecast Period | 2022-2030 |
| Base Year | 2022 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Report Segmentation and Scope:
The angioplasty balloons market analysis has been carried out by considering the following segments: type, application, and end user.
Segmental Analysis:
By type, the angioplasty balloons market is segmented into normal balloons, drug eluting balloons, cutting balloons, and scoring balloons. The normal balloons segment held the largest market share in 2022. However, the drug eluting balloons segment is anticipated to register the highest CAGR during 2022–2030.
By application, the angioplasty balloons market is bifurcated into peripheral and coronary. The coronary segment held a larger angioplasty balloons market share in 2022 and is anticipated to register the highest CAGR during 2022–2030 due to the increasing prevalence of coronary artery diseases, especially heart disease. As per the March 2023 update from the Centers for Disease Control and Prevention (CDC), coronary heart disease is the most prevalent type of heart disease, affecting approximately 1 in 20 persons aged 20 and above. However, the peripheral segment is anticipated to register a higher CAGR during 2022–2030.
The angioplasty balloons market, based on end user, is segmented into hospitals, ambulatory surgery centers, and cath labs. The hospitals segment held the largest angioplasty balloons market share in 2022 and is anticipated to register the highest CAGR during 2022–2030.
Regional Analysis:
The geographic scope of the angioplasty balloons market report includes North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America held the largest market share in 2022. The market growth in North America is driven by the increasing burden of an aging population, rising number of product launches, and R&D activities to develop advanced angioplasty balloons.
Angioplasty Balloons Market Report Scope
Competitive Landscape and Key Companies:
Abbott, Boston Scientific Corporation, Cardinal Health, Cook Medical, C. R. Bard Inc, ENDOCOR GmbH, Medtronic, Spectranetics, BIOTRONIK, and Terumo Medical Corporation are among the prominent companies profiled in the angioplasty balloons market report. These companies focus on developing new technologies, upgrading existing products, and expanding their geographic presence to meet the growing consumer demand worldwide. As per company press releases, below are a few recent key developments:
- In March 2023, in the US, SIS Medical AG introduced the OPN NC PTCA Dilatation Catheter with TWIN-Wall technology. By offering great performance and safety along with success rates where other balloons fail, the product expands therapy possibilities. The OPN NC catheter features a TWIN-Wall design, which offers a super-high pressure resistance with a rated burst pressure of 35 atm with a significantly low compliance.
- In September 2022, the FDA granted Advanced NanoTherapies a Breakthrough Device Designation (BDD) for its SirPlux Duo Drug-Coated Balloon (DCB) to treat coronary artery disease. SirPlux Duo DCB delivers low-dose, long-term release of both compounds to inhibit cell growth, resulting in maximum potency exceeding any other DCB or drug-eluting stent.
- In January 2022, The Scoreflex NC Scoring PTCA Catheter received Premarket Approval (PMA) from the US Food and Drug Administration (FDA). The Scoreflex NC is a scoring PTCA catheter indicated for the de novo stenotic portion of a coronary artery and in-stent restenosis in coronary arteries in patients evident with coronary ischemia for the purpose of improving myocardial perfusion.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Application, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The angioplasty balloonss market, based on end user, is segmented into hospitals, ambulatory surgery centers, and cath labs. The hospitals segment held the largest angioplasty balloons market share in 2022 and is anticipated to register the highest CAGR during 2022–2030.
Asia Pacific is expected to be the fastest-growing region in the angioplasty balloonss market. The region occupies a significant position in the global angioplasty balloons market and is expected to demonstrate a promising growth trajectory during the forecast period. The driving factors for the growth of the market are the increasing prevalence of cardiovascular diseases, growing aging population, improving healthcare infrastructure, and rising awareness about minimally invasive procedures.
The angioplasty balloonss market, based on application, is is bifurcated into peripheral and coronary. The coronary segment held a larger angioplasty balloons market share in 2022 and is anticipated to register the highest CAGR during 2022–2030.
The angioplasty balloonss market, based on type, is segmented into normal balloons, drug eluting balloons, cutting balloons, and scoring balloons. The normal balloons segment held the largest market share in 2022. However, the drug eluting balloons segment is anticipated to register the highest CAGR during 2022–2030.
US holds the largest market share in angioplasty balloonss market due to the increasing cases of heart disease. According to the American Heart Association, due to cardiovascular diseases, one person dies every 34 seconds in the US. In 2020, ~697,000 people in the US died from heart disease, i.e., one in every five deaths.
An angioplasty is a technique used to open widen up narrowed or open clogged coronary arteries and restore blood flow. Value-based care, which focuses on cost-effectiveness and patient outcomes, is changing the healthcare sector. The market for angioplasty balloons will be influenced by the capacity of these devices to provide better patient outcomes, lower reduced rates of revascularization, and lower costs as compared to other available treatments. Compared to conventional surgical methods, angioplasty balloons provide a less invasive method of treating clogged arteries. The need for angioplasty balloons is rising as patients and medical professionals show a greater preference for less invasive procedures.
The angioplasty balloonss market majorly consists of players such as Abbott, Boston Scientific Corporation, Cardinal Health, Cook Medical, C. R. Bard Inc, ENDOCOR GmbH, Medtronic, Spectranetics, BIOTRONIK, and Terumo Medical Corporation among others.
The factors that are driving the growth of the market are the rising prevalence of cardiovascular diseases and rising increasing preference for minimally invasive procedures.
1. Introduction
1.1 Scope of the Study
1.2 Market Definition, Assumptions and Limitations
1.3 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Market Attractiveness Analysis
3. Research Methodology
4. Angioplasty Balloon Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
4.3.1 List of Vendors in the Value Chain
5. Angioplasty Balloon Market - Key Market Dynamics
5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
5.5 Impact Analysis of Drivers and Restraints
6. Angioplasty Balloon Market - Global Market Analysis
6.1 Angioplasty Balloon - Global Market Overview
6.2 Angioplasty Balloon - Global Market and Forecast to 2030
7. Angioplasty Balloon Market – Revenue Analysis (USD Million) – By Type, 2020-2030
7.1 Overview
7.2 Normal Balloons
7.3 Drug Eluting Balloons
7.4 Scoring Balloons
7.5 Cutting Balloon
8. Angioplasty Balloon Market – Revenue Analysis (USD Million) – By Application, 2020-2030
8.1 Overview
8.2 Coronary
8.3 Peripheral
9. Angioplasty Balloon Market – Revenue Analysis (USD Million) – By End User, 2020-2030
9.1 Overview
9.2 Hospitals
9.3 Ambulatory Surgery Centers
9.4 Cath Labs
10. Angioplasty Balloon Market - Revenue Analysis (USD Million), 2020-2030 – Geographical Analysis
10.1 North America
10.1.1 North America Angioplasty Balloon Market Overview
10.1.2 North America Angioplasty Balloon Market Revenue and Forecasts to 2030
10.1.3 North America Angioplasty Balloon Market Revenue and Forecasts and Analysis - By Type
10.1.4 North America Angioplasty Balloon Market Revenue and Forecasts and Analysis - By Material
10.1.5 North America Angioplasty Balloon Market Revenue and Forecasts and Analysis - By Application
10.1.6 North America Angioplasty Balloon Market Revenue and Forecasts and Analysis - By End User
10.1.7 North America Angioplasty Balloon Market Revenue and Forecasts and Analysis - By Countries
10.1.7.1 United States Angioplasty Balloon Market
10.1.7.1.1 United States Angioplasty Balloon Market, by Type
10.1.7.1.2 United States Angioplasty Balloon Market, by Material
10.1.7.1.3 United States Angioplasty Balloon Market, by Application
10.1.7.1.4 United States Angioplasty Balloon Market, by End User
10.1.7.2 Canada Angioplasty Balloon Market
10.1.7.2.1 Canada Angioplasty Balloon Market, by Type
10.1.7.2.2 Canada Angioplasty Balloon Market, by Material
10.1.7.2.3 Canada Angioplasty Balloon Market, by Application
10.1.7.2.4 Canada Angioplasty Balloon Market, by End User
10.1.7.3 Mexico Angioplasty Balloon Market
10.1.7.3.1 Mexico Angioplasty Balloon Market, by Type
10.1.7.3.2 Mexico Angioplasty Balloon Market, by Material
10.1.7.3.3 Mexico Angioplasty Balloon Market, by Application
10.1.7.3.4 Mexico Angioplasty Balloon Market, by End User
Note - Similar analysis would be provided for below mentioned regions/countries
10.2 Europe
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 Spain
10.2.5 United Kingdom
10.2.6 Rest of Europe
10.3 Asia-Pacific
10.3.1 Australia
10.3.2 China
10.3.3 India
10.3.4 Japan
10.3.5 South Korea
10.3.6 Rest of Asia-Pacific
10.4 Middle East and Africa
10.4.1 South Africa
10.4.2 Saudi Arabia
10.4.3 U.A.E
10.4.4 Rest of Middle East and Africa
10.5 South and Central America
10.5.1 Brazil
10.5.2 Argentina
10.5.3 Rest of South and Central America
11. Industry Landscape
11.1 Mergers and Acquisitions
11.2 Agreements, Collaborations, Joint Ventures
11.3 New Product Launches
11.4 Expansions and Other Strategic Developments
12. Competitive Landscape
12.1 Heat Map Analysis by Key Players
12.2 Company Positioning and Concentration
13. Angioplasty Balloon Market - Key Company Profiles
13.1 Abbott
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
Note - Similar information would be provided for below list of companies
13.2 Boston Scientific Corporation
13.3 Cardinal Health
13.4 Cook Medical
13.5 BD (C. R. Bard, Inc.)
13.6 ENDOCOR GmbH
13.7 Medtronic
13.8 Spectranetics
13.9 BIOTRONIK
13.10 Terumo Medical Corporation
14. Appendix
14.1 Glossary
14.2 About The Insight Partners
14.3 Market Intelligence Cloud
The List of Companies - Angioplasty Balloons Market
- Abbott
- Boston Scientific Corporation
- Cardinal Health
- Cook Medical
- C. R. Bard Inc
- ENDOCOR GmbH
- Medtronic
- Spectranetics
- BIOTRONIK
- Terumo Medical Corporation
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Angioplasty Balloons Market
Mar 2024
Dental Laser Treatment Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Hard Tissue, Soft Tissue, and Others), End User (Hospitals, Dental Clinics, Dental-Owned Practices, and Others), Clinical Indication [Conservative Dentistry, Root Canal (Endodontic Treatment), Oral Surgery, Implantology, Peri-Implantitis, Periodontics, and Others], and Geography
Mar 2024
Antimicrobial Surgical Suture Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Triclosan Antimicrobial Suture and Chlorhexidine Antimicrobial Suture), Raw Materials (Polyglactin 910 Antimicrobial Suture, Poliglecaprone 25, and Polyglycolic Acid), Application (Cardiovascular Surgery, General Surgery, Ophthalmic Surgery, Gynecological Surgery, Orthopedic Surgery, Plastic Surgery, Veterinary Surgery, Dental Surgery, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2024
Smart Hospital Beds Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Patient Weight (Less than 70 lb, 70 to 150 lb, 150 to 400 lb, 400 to 500 lb, Greater than 500 lb); Offering (Products and Accessories, Software and Solutions, and Services); Application (Fall Prevention, Pressure Injury Prevention, Patient Deterioration and Monitoring, and Others); End User (Hospitals, Clinics and Nursing Homes, Ambulatory Surgical Centers, Medical Laboratories, Long Term Care Centers, and Others), and Geography
Mar 2024
Heart Transplant Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Surgery Type (Orthotopic Heart Transplant and Heterotopic Heart Transplant), Type (Donor Live Heart and Artificial Hearts), End User (Hospitals, Cardiac Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2024
Breath Analyzer Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Fuel Cell Technology, Semiconductor Sensor, Infrared Spectroscopy, and Others), Application (Drug Abuse Detection, Alcohol Detection, and Medical Applications), End User (Law Enforcement Agencies, Hospitals & Diagnostic Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2024
Osteoarthritis Therapy Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type (TENS, Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others), Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals and Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography
Mar 2024
Surgical Navigation Systems Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Optical Navigation System, Electromagnetic Navigation System, Hybrid Navigation System, Fluoroscopy Navigation System, CT-Based Navigation System, and Others), Application (Orthopedic, ENT, Neurology, Dental, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography
Mar 2024
Skull Clamp Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Three-Pin Skull Clamp, Four-Pin Skull Clamp, and Two-Pin Skull Clamp), Application (Surgery and Medical Imaging), Material (Stainless Steel, Aluminum Alloy, Titanium, and Radiolucent), Accessories (Skull Pins, Headrest, and Others), End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Get Free Sample For